Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans-Reference-Cited by-同舟云学术

Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans

Published:2010-09 Issue:9 Volume:16 Page:1245-1256
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jensen Michael C.,Popplewell Leslie,Cooper Laurence J.,DiGiusto David,Kalos Michael,Ostberg Julie R.,Forman Stephen J.

Funder

National Institutes of Health

General Clinical Research Center

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Current status of immunotherapy in B cell malignancies;Kofler;Curr Drug Targets,2006

2. A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma;Molina;Annu Rev Med,2008

3. Immunomodulation in the treatment of haematological malignancies;Cesco-Gaspere;Clin Exp Med,2009

4. Immunotherapy for lymphomas;Timmerman;Int J Hematol,2003

5. The promise and potential pitfalls of chimeric antigen receptors;Sadelain;Curr Opin Immunol,2009

Cited by 452 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. CAR-T therapy for ovarian cancer: Recent advances and future directions;Biochemical Pharmacology;2024-08

3. Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas;Frontiers in Oncology;2024-07-01

4. Small molecule-regulated switches to provide functional control of CAR T cells within the patient;Expert Opinion on Biological Therapy;2024-06-02

5. The Unprecedented Success of Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Hematological Malignancies;Cureus;2024-05-09